Who Owns Tenaya Therapeutics Stock?
NASDAQ: TNYAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 48.86%
- Held by insiders
- 0.48%
- Institutional holders
- 125
- Institutions 48.9%
- Insiders 0.5%
- Public and other 50.7%
Who owns Tenaya Therapeutics stock?
Institutional investors own about 48.9% of Tenaya Therapeutics's shares, spread across 125 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.48% of TNYA.
The largest institutional holders are Vanguard Capital Management LLC (3.17%), Millennium Management Llc (2.87%) and Citadel Advisors Llc (2.04%). Together, the top 10 institutions control 18.0% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TNYA positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TNYA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 7.10M | 3.17% | -16.3% |
| Millennium Management Llc | 6.43M | 2.87% | +17.8% |
| Citadel Advisors Llc | 4.57M | 2.04% | +8.7% |
| Renaissance Technologies, LLC | 4.28M | 1.91% | +15.3% |
| Blackrock Inc. | 4.01M | 1.79% | +8.2% |
| Empery Asset Management, LP | 3.86M | 1.72% | -9.9% |
| Marshall Wace LLP | 3.50M | 1.56% | +29.5% |
| GSA Capital Partners LLP | 2.67M | 1.19% | +148.8% |
| Burkehill Global Management, LP | 2.00M | 0.89% | 0.0% |
| Geode Capital Management, LLC | 1.83M | 0.82% | +17.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TNYA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.14M | 2.29% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.77M | 0.79% |
| iShares Trust-iShares Biotechnology ETF | 1.57M | 0.70% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 550.29K | 0.25% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 302.89K | 0.14% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 231.32K | 0.10% |
| Invesco Exchange-Traded Fund Trust-Invesco RAFI US 1500 Small-Mid ETF | 221.85K | 0.10% |
| GOLDMAN SACHS TRUST-Goldman Sachs Absolute Return Tracker Fund | 161.86K | 0.07% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 131.80K | 0.06% |
| Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF | 128.68K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Tenaya Therapeutics?
Vanguard Capital Management LLC is the largest institutional shareholder of TNYA, owning 3.17% of shares outstanding (7.10M shares) as of its latest 13F filing.
What percentage of Tenaya Therapeutics is owned by institutions?
Institutions own about 48.9% of TNYA shares and 49.1% of the public float.
How much of Tenaya Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.48% of TNYA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.